Loss of Cannabinoid CB1 Receptors in the Basal Ganglia in the Late Akinetic Phase of Rats with Experimental Huntington's Disease

By Lastres-Becker Isabel   Gómez María   de Miguel Rosario   Ramos José A.   Fernández-Ruiz Javier  

Neurotoxicity Research, Vol. 4, Iss. 7-8, 2002-01 ,pp. : 601-608

Springer Publishing Company

Access to resources Recommend Favorite

Stimulation of CB1 Cannabinoid and NMDA Receptors Increases Neuroprotective Effect against Diazinon-Induced Neurotoxicity

By Bahrami F.   Hashemi M.   Khalili F.   Hashemi J.   Asgari A.  

Neurophysiology, Vol. 45, Iss. 5-6, 2013-11 ,pp. : 433-440

Springer Publishing Company

Access to resources Recommend Favorite

Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease

By Ryu J.K.   Kim S.U.   McLarnon J.G.  

Experimental Neurology, Vol. 183, Iss. 2, 2003-10 ,pp. : 700-704

Elsevier

Access to resources Recommend Favorite

CB1 cannabinoid receptors in amphibian spinal cord: relationships with some nociception markers

By Salio C.   Cottone E.   Conrath M.   Franzoni M.F.  

Journal of Chemical Neuroanatomy, Vol. 24, Iss. 3, 2002-09 ,pp. : 153-162

Elsevier

Access to resources Recommend Favorite

Deficits in Striatal Dopamine D 2 Receptors and Energy Metabolism Detected by in Vivo MicroPET Imaging in a Rat Model of Huntington's Disease

By Araujo D.M.   Cherry S.R.   Tatsukawa K.J.   Toyokuni T.   Kornblum H.I.  

Experimental Neurology, Vol. 166, Iss. 2, 2000-12 ,pp. : 287-297

Elsevier

Access to resources Recommend Favorite